Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引：0
|
作者：
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis
    Hee-Jin Park
    Min-Chan Park
    Yong-Beom Park
    Soo-Kon Lee
    Sang-Won Lee
    Rheumatology International, 2014, 34 : 833 - 840
  • [32] LIVER BIOPSIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING METHOTREXATE - WHERE ARE WE GOING
    KREMER, JM
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (02) : 189 - 191
  • [33] Risk of Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Treated with Methotrexate
    Wan, Joy
    Zhang, He
    Ogdie, Alexis
    Egeberg, Alexander
    Gelfand, Joel M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 12 - 12
  • [34] Interstitial lung disease in rheumatoid arthritis patients receiving leflunomide.
    Cannon, GW
    Strand, V
    Simon, LS
    Kavanaug, AF
    Hochberg, MC
    Scarazzini, L
    Holden, WL
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S561 - S561
  • [35] Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate
    Olsson-White, Debbie A.
    Olynyk, John K.
    Ayonrinde, Oyekoya T.
    Paramalingam, Shereen
    Keen, Helen, I
    INTERNAL MEDICINE JOURNAL, 2022, 52 (04) : 566 - 573
  • [36] Leflunomide improves active rheumatoid arthritis equivalently to methotrexate
    Cronstein, BN
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (04) : 369 - 370
  • [37] Prevalence of Liver Fibrosis Detected by Transient Elastography in Rheumatoid Arthritis Patients Treated with Methotrexate
    Proyklang, Thanakrit
    Chuenyong, Kitti
    Sumethkul, Kittiwan
    Hansomburana, Piyathida
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 696 - 696
  • [38] THE ROLE OF ENHANCED LIVER FIBROSIS (ELF) SCORE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH METHOTREXATE
    Swierkot, J.
    Frankowski, M.
    Skoczynska, M.
    Starba, A.
    Gomulkiewicz, M. S.
    Wojtala, P.
    Bujak, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 276 - 276
  • [39] THE EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH METHOTREXATE AND LEFLUNOMIDE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Stanislavchuk, M. A.
    Shevchuk, S. V.
    Ursol, N. B.
    RHEUMATOLOGY, 2003, 42 : 97 - 97
  • [40] Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate
    Kremer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : 695 - 696
12345